HALEON PLC-ADR (HLN) Fundamental Analysis & Valuation

NYSE:HLN • US4055521003

Current stock price

9.775 USD
+0.08 (+0.77%)
Last:

This HLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. HLN Profitability Analysis

1.1 Basic Checks

  • In the past year HLN was profitable.
  • In the past year HLN had a positive cash flow from operations.
  • In the past 5 years HLN has always been profitable.
  • In the past 5 years HLN always reported a positive cash flow from operatings.
HLN Yearly Net Income VS EBIT VS OCF VS FCFHLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • With an excellent Return On Assets value of 5.11%, HLN belongs to the best of the industry, outperforming 86.01% of the companies in the same industry.
  • HLN has a Return On Equity of 10.15%. This is amongst the best in the industry. HLN outperforms 84.46% of its industry peers.
  • HLN has a Return On Invested Capital of 7.04%. This is amongst the best in the industry. HLN outperforms 83.94% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 13.06%.
  • The 3 year average ROIC (6.87%) for HLN is below the current ROIC(7.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROIC 7.04%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
HLN Yearly ROA, ROE, ROICHLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of HLN (15.11%) is better than 88.60% of its industry peers.
  • In the last couple of years the Profit Margin of HLN has grown nicely.
  • HLN has a better Operating Margin (22.78%) than 89.12% of its industry peers.
  • In the last couple of years the Operating Margin of HLN has remained more or less at the same level.
  • HLN has a better Gross Margin (65.01%) than 73.58% of its industry peers.
  • HLN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
HLN Yearly Profit, Operating, Gross MarginsHLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HLN Health Analysis

2.1 Basic Checks

  • HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, HLN has less shares outstanding
  • Compared to 5 years ago, HLN has less shares outstanding
  • HLN has a better debt/assets ratio than last year.
HLN Yearly Shares OutstandingHLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
HLN Yearly Total Debt VS Total AssetsHLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • HLN has an Altman-Z score of 2.48. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.48, HLN is in the better half of the industry, outperforming 67.36% of the companies in the same industry.
  • HLN has a debt to FCF ratio of 3.87. This is a good value and a sign of high solvency as HLN would need 3.87 years to pay back of all of its debts.
  • HLN's Debt to FCF ratio of 3.87 is amongst the best of the industry. HLN outperforms 87.56% of its industry peers.
  • A Debt/Equity ratio of 0.47 indicates that HLN is not too dependend on debt financing.
  • HLN has a worse Debt to Equity ratio (0.47) than 61.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Altman-Z 2.48
ROIC/WACC0.79
WACC8.9%
HLN Yearly LT Debt VS Equity VS FCFHLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.92 indicates that HLN may have some problems paying its short term obligations.
  • The Current ratio of HLN (0.92) is worse than 84.97% of its industry peers.
  • HLN has a Quick Ratio of 0.92. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.71, HLN is doing worse than 84.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.71
HLN Yearly Current Assets VS Current LiabilitesHLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HLN Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.59% over the past year.
  • Measured over the past years, HLN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.56% on average per year.
  • Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
  • HLN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%

3.2 Future

  • HLN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.38% yearly.
  • The Revenue is expected to grow by 3.26% on average over the next years.
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue Next Year-1.37%
Revenue Next 2Y1.08%
Revenue Next 3Y2.23%
Revenue Next 5Y3.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HLN Yearly Revenue VS EstimatesHLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
HLN Yearly EPS VS EstimatesHLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. HLN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.36 indicates a rather expensive valuation of HLN.
  • Based on the Price/Earnings ratio, HLN is valued cheaply inside the industry as 81.87% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 25.50. HLN is valued slightly cheaper when compared to this.
  • HLN is valuated rather expensively with a Price/Forward Earnings ratio of 17.18.
  • Based on the Price/Forward Earnings ratio, HLN is valued cheaper than 80.31% of the companies in the same industry.
  • HLN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.67.
Industry RankSector Rank
PE 20.36
Fwd PE 17.18
HLN Price Earnings VS Forward Price EarningsHLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HLN is valued cheaply inside the industry as 82.90% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, HLN is valued cheaply inside the industry as 86.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.66
EV/EBITDA 13.78
HLN Per share dataHLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HLN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.22
PEG (5Y)1.16
EPS Next 2Y8.54%
EPS Next 3Y8.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HLN Dividend Analysis

5.1 Amount

  • HLN has a Yearly Dividend Yield of 1.87%.
  • HLN's Dividend Yield is rather good when compared to the industry average which is at 0.79. HLN pays more dividend than 92.23% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, HLN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.87%

5.2 History

  • HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of HLN decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
HLN Yearly Dividends per shareHLN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 36.71% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP36.71%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
HLN Yearly Income VS Free CF VS DividendHLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
HLN Dividend Payout.HLN Dividend Payout, showing the Payout Ratio.HLN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HLN Fundamentals: All Metrics, Ratios and Statistics

HALEON PLC-ADR

NYSE:HLN (3/25/2026, 11:06:49 AM)

9.775

+0.08 (+0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners60.22%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap43.54B
Revenue(TTM)11.23B
Net Income(TTM)1.67B
Analysts80
Price Target11.91 (21.84%)
Short Float %0.38%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield 1.87%
Yearly Dividend0.18
Dividend Growth(5Y)N/A
DP36.71%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-10
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-1.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.44%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-1.69%
Revenue beat(8)0
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.16%
PT rev (3m)4.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.66%
EPS NY rev (3m)-1.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE 20.36
Fwd PE 17.18
P/S 2.95
P/FCF 14.66
P/OCF 12.36
P/B 1.98
P/tB N/A
EV/EBITDA 13.78
EPS(TTM)0.48
EY4.91%
EPS(NY)0.57
Fwd EY5.82%
FCF(TTM)0.67
FCFY6.82%
OCF(TTM)0.79
OCFY8.09%
SpS3.31
BVpS4.93
TBVpS-2.76
PEG (NY)3.22
PEG (5Y)1.16
Graham Number7.3
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROCE 9.07%
ROIC 7.04%
ROICexc 7.4%
ROICexgc 256.74%
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
FCFM 20.14%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
ROICexc(3y)7.38%
ROICexc(5y)6.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.85%
ROCE(5y)8.36%
ROICexgc growth 3Y31.03%
ROICexgc growth 5Y32.63%
ROICexc growth 3Y5.68%
ROICexc growth 5Y5.43%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Debt/EBITDA 2.71
Cap/Depr 114.72%
Cap/Sales 3.74%
Interest Coverage 7.04
Cash Conversion 91.68%
Profit Quality 133.23%
Current Ratio 0.92
Quick Ratio 0.71
Altman-Z 2.48
F-Score8
WACC8.9%
ROIC/WACC0.79
Cap/Depr(3y)107.2%
Cap/Depr(5y)109.42%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.14%
Profit Quality(3y)146.3%
Profit Quality(5y)135.74%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%
Revenue Next Year-1.37%
Revenue Next 2Y1.08%
Revenue Next 3Y2.23%
Revenue Next 5Y3.26%
EBIT growth 1Y-1.26%
EBIT growth 3Y1.06%
EBIT growth 5Y2.67%
EBIT Next Year20.78%
EBIT Next 3Y10.91%
EBIT Next 5Y9.2%
FCF growth 1Y12%
FCF growth 3Y8.58%
FCF growth 5Y15.32%
OCF growth 1Y14.47%
OCF growth 3Y8.49%
OCF growth 5Y13.36%

HALEON PLC-ADR / HLN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to HLN.


Can you provide the valuation status for HALEON PLC-ADR?

ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.


How profitable is HALEON PLC-ADR (HLN) stock?

HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for HLN stock?

The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.36 and the Price/Book (PB) ratio is 1.98.


Can you provide the dividend sustainability for HLN stock?

The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 36.71%.